已收录 273170 条政策
 政策提纲
  • 暂无提纲
Understanding Medication Nonadherence after Kidney Transplant
[摘要] Alloimmunity remains a barrier to long-term graft survival that necessitates lifelong immunosuppressive therapy after renal transplant. Medication nonadherence has been increasingly recognized as a major impediment to achieving effective immunosuppression. Electronic medication monitoring further reveals that nonadherence manifests early after transplant, although the effect is delayed. The etiology of nonadherence is multifactorial, with the strongest risk factors including past nonadherence and being an adolescent or young adult. Other risk factors with smaller but consistently important effects include minority race/ethnicity, poor social supports, and poor perceived health. In children, risk factors related to parental and child psychologic and behavioral functioning and parental distress and burden are also important. Qualitative systematic reviews highlight the need to tailor interventions to each transplant recipient’s unique needs, motivations, and barriers rather than offer a one size fits all approach. To date, relatively few interventions have been studied, and most studies conducted were underpowered to allow definitive conclusions. If the kidney transplant community’s goal of “one transplant for life” is to become a reality, then solutions for medication nonadherence must be found and implemented.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 泌尿医学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文